- The trend backdrop is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
PEXA-B
STO
Week ended 07 Aug 2026
Weekly Investor Report
PExA AB · Healthcare · Medical Devices
Latest close
0.42 SEK
-9.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 43.6% above the Trend Line and sits at 47.4% of its 52-week range. The latest completed week returned -9.4%, after a -7.0% four-week move. The latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal.
Setup score
50
out of 100
Latest Close
0.42 SEK
7 Aug 2026
1W Return
-9.4%
latest completed week
4W Return
-7.0%
short-term follow-through
12W Return
100.5%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- Next-week expectancy is negative at 34.75% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-9.4%
Latest completed week; four-week move -7.0%.
Indicator stack
48/66
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.75%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
48/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 43.6% above the Trend Line and sits at 47.4% of its 52-week range. The latest completed week returned -9.4%, after a -7.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6912-week average 0.39
12-week confirmation
Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.0% over four weeks, 100.5% over 12 weeks, and 131.8% over one year. The current trend has remained active for 8 consecutive weeks.
Performance by holding period
Active trend streak8 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change-20.9%Four-week change in activity pressure.
Leadership44.02Latest relative-leadership reading.
RS change-38.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 2 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-42.9%Distance below the 52-week high.
13-week volatility29.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+89.9%Week of 26 Jun.
Worst week-32.2%Week of 3 Jul.
Latest week-9.4%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains3
Flat weeks0
Modest losses1
Sharp losses11
Recent vol29.1%13-week weekly-return volatility.
Base vol19.2%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew14.1% / -10.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank- / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Medical Devices
4-week rank35 / 46
Group average-3.1%
Trend breadth23.9%
Trend23.9%active weekly trend signals
MD41.3%positive activity pressure
RS10.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape45/100
Trend, activity pressure, participation, and risk combine to a 45/100 tape read.
Indicator analysis70/100Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 10/12.
Activity pressure 0.69; 2 reversal markers Next-Week ExpectancyNegative 34.75%Next-week expectancy is negative with a 34.75% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 3 relevant articles.
PEXA flags debt covenant breach after regulator floats ‘unsustainable’ pricing cap Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.42 SEK | -9.4% | 0.30 SEK | 0.33 SEK | 0.97 | 44.02 | 514.0K | On |
| 31 Jul 2026 | 0.47 SEK | -9.1% | 0.29 SEK | 0.33 SEK | 1.24 | 64.18 | 873.7K | On |
| 24 Jul 2026 | 0.52 SEK | -9.5% | 0.28 SEK | 0.33 SEK | 1.26 | 85.42 | 1.4M | On |
| 17 Jul 2026 | 0.57 SEK | 24.7% | 0.27 SEK | 0.33 SEK | 1.37 | 111.67 | 1.7M | On |
| 10 Jul 2026 | 0.46 SEK | 28.2% | 0.26 SEK | 0.33 SEK | 1.22 | 71.28 | 4.3M | On |
| 3 Jul 2026 | 0.36 SEK | -32.2% | 0.25 SEK | 0.33 SEK | 1.10 | 32.04 | 471.5K | On |
| 26 Jun 2026 | 0.53 SEK | 89.9% | 0.25 SEK | 0.33 SEK | 1.17 | 99.91 | 2.3M | On |
| 19 Jun 2026 | 0.28 SEK | -7.0% | 0.24 SEK | 0.33 SEK | 1.04 | 6.28 | 216.3K | On |
| 12 Jun 2026 | 0.30 SEK | -6.6% | 0.24 SEK | 0.33 SEK | 0.84 | 16.50 | 61.9K | Off |
| 5 Jun 2026 | 0.32 SEK | 27.6% | 0.24 SEK | 0.34 SEK | 0.53 | 24.28 | 788.6K | Off |
| 29 May 2026 | 0.25 SEK | 11.1% | 0.24 SEK | 0.34 SEK | 0.32 | -3.01 | 3.5M | Off |
| 22 May 2026 | 0.23 SEK | 6.1% | 0.24 SEK | 0.34 SEK | 0.21 | -13.81 | 653.6K | Off |
| 15 May 2026 | 0.21 SEK | -7.0% | 0.24 SEK | 0.34 SEK | 0.30 | -16.61 | 725.6K | Off |
| 8 May 2026 | 0.23 SEK | -13.0% | 0.24 SEK | 0.34 SEK | 0.22 | -11.90 | 2.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.